evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract
18685,GENE_SUMMARY,,"TNFRSF14 encodes tumour necrosis factor receptor superfamily 14, that regulates a variety of physiological and pathological responses in both innate and acquired immunity. TNFRSF14 mutations and deregulation are present in several types of cancer but most frequently in follicular lymphoma.",,2017-01-18,,8764,TNFRSF14,tumor necrosis factor receptor superfamily member 14,False,ENST00000355716,NM_003820.2,HVEM,CD270,TR2,HVEA,ATAR,LIGHTR,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
18686,GENE_BACKGROUND,,"TNFRSF14 encodes the tumour necrosis factor receptor superfamily 14, also known as Herpes virus entry mediator (HVEM) (PMID: 8898196). It is expressed on several types of cells, including T cells, B cells, NK cells, dendritic cells, and myeloid cells, as well as non-lymphoid organs including lung, liver and kidney (PMID: 9162061). TNFRSF14 is a tumor suppressor and immunogenicity regulation factor and is capable of sending both stimulatory and inhibitory signals to T cells depending on the particular ligand it binds (PMID: 23023713, 20884631). Mutations in TNFRSF14 has been demonstrated in the pathogenesis of both diffuse large B-cell lymphoma (PMID: 22343534 ) and follicular lymphoma (FL) (PMID: 20884631, 24435047, 24162788, 21941365). These mutations are associated with high-risk clinical features, and patients with a mutation in TNFRSF14 responded poorly to rituximab (PMID: 20884631). Recurrent copy number loss of the region containing TNFRSF14 was observed in 42% of the cases with classical Hodgkin lymphoma (CHL) (PMID:26650888). Finally, TNFRSF14 expression is deregulated in colorectal cancer (PMID: 25750286), hepatocellular carcinoma (PMID: 25468715) and esophageal squamous cell carcinoma (PMID:24249528).",,2017-01-18,,8764,TNFRSF14,tumor necrosis factor receptor superfamily member 14,False,ENST00000355716,NM_003820.2,HVEM,CD270,TR2,HVEA,ATAR,LIGHTR,False,20884631,Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.,Cancer research,2018-11-15T20:10:00,70,22,9166-74,Cheung KJ et al,doi: 10.1158/0008-5472.CAN-10-2460,,0001-11-15,,26650888,Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.,"Genes, chromosomes &amp; cancer",2018-03-01T20:16:00,55,3,278-87,Salipante SJ et al,doi: 10.1002/gcc.22331,,0001-03-01,,24249528,Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma.,Cancer,2018-03-15T20:14:00,120,6,808-17,Migita K et al,doi: 10.1002/cncr.28491,,0001-03-15,,21941365,High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.,Leukemia,2018-03-01T20:12:00,26,3,559-62,Launay E et al,doi: 10.1038/leu.2011.266,,0001-03-01,,24435047,"Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.",Blood,2018-03-06T20:14:00,123,10,1487-98,Li H et al,doi: 10.1182/blood-2013-05-500264,,0001-03-06,,23023713,Pathogenesis of follicular lymphoma.,The Journal of clinical investigation,2018-10-01T20:12:00,122,10,3424-31,Kridel R et al,doi: 10.1172/JCI63186,,0001-10-01,,22343534,Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.,Proceedings of the National Academy of Sciences of the United States of America,2018-03-06T20:12:00,109,10,3879-84,Lohr JG et al,doi: 10.1073/pnas.1121343109,,0001-03-06,,25750286,HVEM expression contributes to tumor progression and prognosis in human colorectal cancer.,Anticancer research,2018-03-01T20:15:00,35,3,1361-7,Inoue T et al,,,0001-03-01,,25468715,Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.,"European journal of cancer (Oxford, England : 1990)",2018-01-01T20:15:00,51,2,157-65,Hokuto D et al,doi: 10.1016/j.ejca.2014.11.004,,0001-01-01,,8898196,Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family.,Cell,0001-11-01,87,3,427-36,Montgomery RI et al,,,0001-11-01,,9162061,A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation.,The Journal of biological chemistry,0001-05-30,272,22,14272-6,Kwon BS et al,,,0001-05-30,,24162788,Early lesions of follicular lymphoma: a genetic perspective.,Haematologica,2018-03-01T20:14:00,99,3,481-8,Mamessier E et al,doi: 10.3324/haematol.2013.094474,,0001-03-01,
